These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

950 related items for PubMed ID: 26440212

  • 1. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
    Jucaud V, Ravindranath MH, Terasaki PI, Morales-Buenrostro LE, Hiepe F, Rose T, Biesen R.
    Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
    [Abstract] [Full Text] [Related]

  • 2. Naturally occurring anti-idiotypic antibodies reactive with anti-DNA antibodies in systemic lupus erythematosus.
    Williams WM, Isenberg DA.
    Lupus; 1998 Mar; 7(3):164-75. PubMed ID: 9607640
    [Abstract] [Full Text] [Related]

  • 3. Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity.
    Pruzanski W, Goulding NJ, Flower RJ, Gladman DD, Urowitz MB, Goodman PJ, Scott KF, Vadas P.
    J Rheumatol; 1994 Feb; 21(2):252-7. PubMed ID: 8182633
    [Abstract] [Full Text] [Related]

  • 4. Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders.
    Saxena R, Sturfelt G, Nived O, Wieslander J.
    Ann Rheum Dis; 1994 Oct; 53(10):659-65. PubMed ID: 7979578
    [Abstract] [Full Text] [Related]

  • 5. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH, Lydolph MC, Westergaard M, Olesen Larsen S, Nielsen CT, Duus K, Jacobsen S, Houen G.
    PLoS One; 2015 Oct; 10(9):e0138753. PubMed ID: 26402865
    [Abstract] [Full Text] [Related]

  • 6. Increased frequency of class I and II anti-human leukocyte antigen antibodies in systemic lupus erythematosus and scleroderma and associated factors: a comparative study.
    Tozkir H, Pamuk ON, Duymaz J, Gurkan H, Yazar M, Sari G, Tanrikulu H, Pamuk GE.
    Int J Rheum Dis; 2016 Dec; 19(12):1304-1309. PubMed ID: 25292400
    [Abstract] [Full Text] [Related]

  • 7. Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus.
    Li YN, Hu FL, Dai YJ, Li R, Ma XX, Du Y, Feng M, Jia Y, Zhang CF, Zhu L, Ascherman DP, Li ZG.
    Lupus; 2014 Aug; 23(9):868-75. PubMed ID: 24704774
    [Abstract] [Full Text] [Related]

  • 8. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
    Hardt U, Larsson A, Gunnarsson I, Clancy RM, Petri M, Buyon JP, Silverman GJ, Svenungsson E, Grönwall C.
    Arthritis Res Ther; 2018 Feb 26; 20(1):36. PubMed ID: 29482604
    [Abstract] [Full Text] [Related]

  • 9. 9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus.
    Jenks SA, Palmer EM, Marin EY, Hartson L, Chida AS, Richardson C, Sanz I.
    Arthritis Rheum; 2013 Dec 26; 65(12):3165-75. PubMed ID: 23983101
    [Abstract] [Full Text] [Related]

  • 10. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
    Bhat NM, Lee LM, van Vollenhoven RF, Teng NN, Bieber MM.
    J Rheumatol; 2002 Oct 26; 29(10):2114-21. PubMed ID: 12375320
    [Abstract] [Full Text] [Related]

  • 11. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
    Villalta D, Bizzaro N, Bassi N, Zen M, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A.
    PLoS One; 2013 Oct 26; 8(8):e71458. PubMed ID: 23951169
    [Abstract] [Full Text] [Related]

  • 12. Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.
    Becker Y, Marcoux G, Allaeys I, Julien AS, Loignon RC, Benk-Fortin H, Rollet-Labelle E, Rauch J, Fortin PR, Boilard E.
    Front Immunol; 2019 Oct 26; 10():1026. PubMed ID: 31134086
    [Abstract] [Full Text] [Related]

  • 13. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.
    O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A.
    Arthritis Rheum; 2010 Mar 26; 62(3):845-54. PubMed ID: 20131231
    [Abstract] [Full Text] [Related]

  • 14. Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus.
    Yang J, Li Q, Yang X, Li M.
    Lupus; 2016 Apr 26; 25(5):513-9. PubMed ID: 26678441
    [Abstract] [Full Text] [Related]

  • 15. Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus.
    Nehring J, Schirmbeck LA, Friebus-Kardash J, Dubler D, Huynh-Do U, Chizzolini C, Ribi C, Trendelenburg M.
    Front Immunol; 2018 Apr 26; 9():2090. PubMed ID: 30333817
    [Abstract] [Full Text] [Related]

  • 16. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.
    Orjuela A, Suwanichkul A, Canter D, Minard CG, Devaraj S, Hicks MJ, Muscal E, Wenderfer SE.
    Am J Nephrol; 2015 Apr 26; 41(3):241-7. PubMed ID: 25926050
    [Abstract] [Full Text] [Related]

  • 17. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
    Pavón EJ, Zumaquero E, Rosal-Vela A, Khoo KM, Cerezo-Wallis D, García-Rodríguez S, Carrascal M, Abian J, Graeff R, Callejas-Rubio JL, Ortego-Centeno N, Malavasi F, Zubiaur M, Sancho J.
    Cytokine; 2013 May 26; 62(2):232-43. PubMed ID: 23538292
    [Abstract] [Full Text] [Related]

  • 18. Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.
    Pradhan V, Pandit P, Rajadhyaksha A, Patwardhan M, Surve P, Kamble P, Lecerf M, Bayry J, Kaveri S, Ghosh K, Nadkar MY.
    J Assoc Physicians India; 2016 May 26; 64(5):14-18. PubMed ID: 27735143
    [Abstract] [Full Text] [Related]

  • 19. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
    Shi H, Ye J, Teng J, Yin Y, Hu Q, Wu X, Liu H, Cheng X, Su Y, Liu M, Gu J, Lu T, Chen H, Zheng H, Sun Y, Yang C.
    Arthritis Res Ther; 2017 Mar 09; 19(1):52. PubMed ID: 28274252
    [Abstract] [Full Text] [Related]

  • 20. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
    Nielsen CT, Østergaard O, Stener L, Iversen LV, Truedsson L, Gullstrand B, Jacobsen S, Heegaard NH.
    Arthritis Rheum; 2012 Apr 09; 64(4):1227-36. PubMed ID: 22238051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.